Persistent Epstein-Barr virus infection: Unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients

被引:65
作者
Hopwood, PA
Brooks, L
Parratt, R
Hunt, BJ
Maria, B
Alero, TJ
Magdi, Y
Crawford, DH
机构
[1] Univ Edinburgh, Div Biomed & Clin Lab Sci, Sch Med, Edinburgh EH8 9XD, Midlothian, Scotland
[2] Univ London London Sch Hyg & Trop Med, Dept Trop Med & Infect Dis, London WC1E 7HT, England
[3] Harefield Hosp, Cardiothorac Unit, Harefield UB9 6JH, Middx, England
[4] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland
[5] St Thomas Hosp, Dept Haematol, London SE1 7EH, England
关键词
D O I
10.1097/00007890-200207270-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Posttransplant lymphoproliferative disease (PTLD) is a common Epstein-Barr virus (EBV)associated complication of transplantation which, despite treatment, is often fatal. This study was undertaken to monitor persistent EBV infection in transplant recipients, to compare EBV load and gene expression in healthy individuals and EBV-associated diseases, and to highlight differences in PTLD that could be used to define those at risk of the disease. Methods. A cohort of 96 cardiothoracic transplant recipients was monitored posttransplant for up to 1110 days (median 268 days). Levels of EBV DNA and viral mRNA transcripts in peripheral blood mononuclear cells (PBMs) were measured at regular intervals and compared with those found in healthy individuals, infectious mononucleosis (IM) patients, and 12 PTLD patients bled at the time of diagnosis. Overall posttransplant levels were significantly higher than pretransplant and healthy subjects, and correlate with dose of immunosuppression. EBV DNA levels in both IM and PTLD were significantly higher than in healthy recipients, with the highest levels in PTLD patients. Individual measurements in 12 healthy transplant recipients reached levels seen in PTLD, and thus single estimations are not of predictive significance for PTLD development. Results. Analysis of viral gene expression in peripheral blood mononuclear cells showed a restricted (LMP 2 only) pattern in healthy subjects, and an unrestricted (latency 3) pattern with lytic replication in 14% of IM blood and 45% of cases of PTLD. A total of 55% of healthy transplant recipients had additional transcripts in one or more blood samples, and this finding correlated with high viral load. Analysis of the 12 samples from healthy recipients with viral loads equivalent to those seen in PTLD showed additional transcripts in all cases and latency 3 with lytic replication in 33%. Thus, an isolated finding of high viral load and/or unrestricted latent and lytic gene expression is not indicative of PTLD.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 53 条
[1]  
ANAGNOSTOPOULOS I, 1989, BLOOD, V74, P810
[2]  
ARMITAGE JM, 1991, J HEART LUNG TRANSPL, V10, P877
[3]   Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients [J].
Babcock, GJ ;
Decker, LL ;
Freeman, RB ;
Thorley-Lawson, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :567-576
[4]   High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders [J].
Baldanti, F ;
Grossi, P ;
Furione, M ;
Simoncini, L ;
Sarasini, A ;
Comoli, P ;
Maccario, R ;
Fiocchi, R ;
Gerna, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :613-619
[5]   EPSTEIN-BARR-VIRUS LATENT GENE-TRANSCRIPTION IN NASOPHARYNGEAL CARCINOMA-CELLS - COEXPRESSION OF EBNA1, LMP1, AND LMP2 TRANSCRIPTS [J].
BROOKS, L ;
YAO, QY ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF VIROLOGY, 1992, 66 (05) :2689-2697
[6]   Large clonal expansions of CD8(+) T cells in acute infectious mononucleosis [J].
Callan, MFC ;
Steven, J ;
Krausa, P ;
Wilson, JDK ;
Moss, PAH ;
Gillespie, GM ;
Bell, JI ;
Rickinson, AB ;
McMichael, AJ .
NATURE MEDICINE, 1996, 2 (08) :906-911
[7]  
CRAWFORD DH, 1986, IMMUNOLOGY, V59, P405
[8]   STUDIES ON LONG-TERM T-CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN IMMUNOSUPPRESSED RENAL-ALLOGRAFT RECIPIENTS [J].
CRAWFORD, DH ;
EDWARDS, JMB ;
SWENY, P ;
HOFFBRAND, AV ;
JANOSSY, G .
INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (06) :705-709
[9]   EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN POSITIVE LYMPHOMA AFTER CYCLOSPORIN-A TREATMENT IN PATIENT WITH RENAL-ALLOGRAFT [J].
CRAWFORD, DH ;
THOMAS, JA ;
JANOSSY, G ;
SWENY, P ;
FERNANDO, ON ;
MOORHEAD, JF ;
THOMPSON, JH .
LANCET, 1980, 1 (8182) :1355-1356
[10]   EPSTEIN-BARR-VIRUS AND HODGKINS-DISEASE - TRANSCRIPTIONAL ANALYSIS OF VIRUS LATENCY IN THE MALIGNANT-CELLS [J].
DEACON, EM ;
PALLESEN, G ;
NIEDOBITEK, G ;
CROCKER, J ;
BROOKS, L ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :339-349